Promoter holding
64.27%
AL
Amn Life Science Private Limited - Due diligence report
A 360° intelligence report on Amn Life: trust score, financial health, credit view, compliance, directors, growth and distress signals - gen…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Amn Life — 360° Intelligence Report
Generated from MCA filings & public records85/100
Trust Score
Low Risk
Amn Life is assessed as Low Risk with a Trust Score of 85/100. Amn Life is an active private limited indian non-government company incorporated in 2003, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Amn Life Science Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
Charges position: 19 open (121.37 cr) · 4 satisfied (19.18 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Sidbi | 12 | 48.0 cr |
| Axis Bank Limited | 2 | 48.0 cr |
| Others | 2 | 48.0 cr |
| Citi Bank N.A. | 2 | 48.0 cr |
| Yes Bank Limited | 1 | 48.0 cr |
| The Hongkong And Shanghai Banking Corporation Limited | 1 | 48.0 cr |
Compliance Score: 86/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 3 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RESHMA ASHISH KHEMKA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ASHISH VIJAY KHEMKA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Amn Life Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: ASHISH VIJAY KHEMKA (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 65 · Distress 65
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
19 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 19 open charge(s) of 121.37 cr already registered.
- Compliance record supports lending.
Investor view75/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
12 Sep 2025
Charge created
Others - 5.00 cr
17 Apr 2025
Charge created
Sidbi - 2.32 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Mar 2024
Charge created
Sidbi - 3.00 cr
21 Mar 2024
Charge created
Sidbi - 4.49 cr
27 Dec 2023
Charge created
Sidbi - 7.25 cr
26 Dec 2023
Charge created
Sidbi - 7.25 cr
12 Dec 2023
Charge created
Others - 15.00 cr
23 Jun 2023
Charge created
Sidbi - 10.00 cr
24 Jan 2023
Charge created
The Hongkong And Shanghai Banking Corporation Limited - 51.00 Lakh
31 Jan 2022
Charge created
Sidbi - 96.00 Lakh
Charge created
Sidbi - 3.00 cr
19 Aug 2021
Charge created
Axis Bank Limited - 16.00 cr
06 Aug 2021
Charge satisfied
Yes Bank Limited
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Kekule Pharma Limited | U24231TG1984PLC005145 | Hyderabad, Telangana, India |
| Pulse Pharmacy | U24239TG1997PTC026151 | Hyderabad, Telangana, India |
| Inject Care Parenterals Private Limited | U24231GJ2002PTC041048 | Vapi, Gujarat, India |
| Wardex Pharmaceuticals Private Limited | U51397TN1946PTC005759 | Madras-29, Tamil Nadu, India |
| Ideal Detonators Private Limited | U24292TG1989PTC010513 | Secunderabad, Telangana, India |
| Class One Agro Biotech & Fertilizer Private Limited | U24129PN2013PTC149228 | Tasgaon, Maharashtra, India |
| Bakson'S Homoeopathic | U74899DL1989PTC036300 | New Delhi, Delhi, India |
| Dwd Pharmaceuticals | U25209MH1970PLC014700 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Amn Life before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Amn Life: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Amn Life - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Amn Life pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Amn Life - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Amn Life an active company?
Amn Life has MCA status “Active” with a compliance score of 86/100 (Low Risk).
Is Amn Life financially healthy?
Amn Life has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Amn Life?
Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Amn Life?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Amn Life have loans or charges against its assets?
19 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.
Is Amn Life up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).
Is it risky to lend to Amn Life?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
